APO Research
Talk to an analyst

APO RESEARCH · REPORT

8-Methoxypsoralen

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global 8-Methoxypsoralen Market Outlook and Growth Opportunities 2026

21 December 2025199 pages

Choose your research edition.

Industry Research8-Methoxypsoralen Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal 8-Methoxypsoralen Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal 8-Methoxypsoralen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 8-Methoxypsoralen Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal 8-Methoxypsoralen Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global 8-Methoxypsoralen market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for 8-Methoxypsoralen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 8-Methoxypsoralen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 8-Methoxypsoralen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the 8-Methoxypsoralen market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the 8-Methoxypsoralen market include Wuxi Sigma Chemical Product, Fisher Scientific, Combi-Blocks, TCI Chemicals, Spectrum-Chemical Products, MP Biomedicals, MedKoo Biosciences, Medical Isotopes and LGM Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global 8-Methoxypsoralen market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 8-Methoxypsoralen and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 8-Methoxypsoralen sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 8-Methoxypsoralen market size, projected growth trends, production technologies, key applications, and end-use industries.

8-Methoxypsoralen Segment by Company

Wuxi Sigma Chemical Product

Fisher Scientific

Combi-Blocks

TCI Chemicals

Spectrum-Chemical Products

MP Biomedicals

MedKoo Biosciences

Medical Isotopes

LGM Pharma

BOC Sciences

ApexBio

Alfa Aesar

ALB Technology

AdipoGen

8-Methoxypsoralen Segment by Type

Oral Type

External Use

8-Methoxypsoralen Segment by Application

Antiarrhythmic Drugs

Anti-inflammatory Drugs

Analgesic Drugs

Others

8-Methoxypsoralen Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global 8-Methoxypsoralen status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions 8-Methoxypsoralen market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify 8-Methoxypsoralen significant trends, drivers, influence factors in global and regions.

6. To analyze 8-Methoxypsoralen competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 8-Methoxypsoralen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 8-Methoxypsoralen and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 8-Methoxypsoralen.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the 8-Methoxypsoralen market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 8-Methoxypsoralen industry.

Chapter 3: Detailed analysis of 8-Methoxypsoralen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of 8-Methoxypsoralen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of 8-Methoxypsoralen in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. 8-Methoxypsoralen Industry Trends Table 2. 8-Methoxypsoralen Industry Drivers Table 3. 8-Methoxypsoralen Industry Opportunities and Challenges Table 4. 8-Methoxypsoralen Industry Restraints Table 5. Global 8-Methoxypsoralen Revenue by Company (US$ Million) & (2021-2026) Table 6. Global 8-Methoxypsoralen Revenue Share by Company (2021-2026) Table 7. Global 8-Methoxypsoralen Sales Volume by Company (k tons) & (2021-2026) Table 8. Global 8-Methoxypsoralen Sales Volume Share by Company (2021-2026) Table 9. Global 8-Methoxypsoralen Average Price (US$/ton) of Company (2021-2026) Table 10. Global 8-Methoxypsoralen Company Ranking, (2024-2026) & (USD Million) Table 11. Global 8-Methoxypsoralen Key Company Manufacturing Base & Headquarters Table 12. Global 8-Methoxypsoralen Company, Product Type & Application Table 13. Global 8-Methoxypsoralen Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global 8-Methoxypsoralen by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Type Table 18. Significant Companies of External Use Table 19. Global 8-Methoxypsoralen Sales Volume by Type 2021 VS 2025 VS 2032 (k tons) Table 20. Global 8-Methoxypsoralen Sales Volume by Type (2021-2026) & (k tons) Table 21. Global 8-Methoxypsoralen Sales Volume by Type (2027-2032) & (k tons) Table 22. Global 8-Methoxypsoralen Sales Volume Share by Type (2021-2026) Table 23. Global 8-Methoxypsoralen Sales Volume Share by Type (2027-2032) Table 24. Global 8-Methoxypsoralen Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global 8-Methoxypsoralen Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global 8-Methoxypsoralen Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global 8-Methoxypsoralen Sales Value Share by Type (2021-2026) Table 28. Global 8-Methoxypsoralen Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Antiarrhythmic Drugs Table 30. Significant Companies of Anti-inflammatory Drugs Table 31. Significant Companies of Analgesic Drugs Table 32. Significant Companies of Others Table 33. Global 8-Methoxypsoralen Sales Volume by Application 2021 VS 2025 VS 2032 (k tons) Table 34. Global 8-Methoxypsoralen Sales Volume by Application (2021-2026) & (k tons) Table 35. Global 8-Methoxypsoralen Sales Volume by Application (2027-2032) & (k tons) Table 36. Global 8-Methoxypsoralen Sales Volume Share by Application (2021-2026) Table 37. Global 8-Methoxypsoralen Sales Volume Share by Application (2027-2032) Table 38. Global 8-Methoxypsoralen Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global 8-Methoxypsoralen Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global 8-Methoxypsoralen Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global 8-Methoxypsoralen Sales Value Share by Application (2021-2026) Table 42. Global 8-Methoxypsoralen Sales Value Share by Application (2027-2032) Table 43. Global 8-Methoxypsoralen Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 44. Global 8-Methoxypsoralen Sales by Region (2021-2026) & (k tons) Table 45. Global 8-Methoxypsoralen Sales Market Share by Region (2021-2026) Table 46. Global 8-Methoxypsoralen Sales by Region (2027-2032) & (k tons) Table 47. Global 8-Methoxypsoralen Sales Market Share by Region (2027-2032) Table 48. Global 8-Methoxypsoralen Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global 8-Methoxypsoralen Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global 8-Methoxypsoralen Sales Value Share by Region (2021-2026) Table 51. Global 8-Methoxypsoralen Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global 8-Methoxypsoralen Sales Value Share by Region (2027-2032) Table 53. Global 8-Methoxypsoralen Market Average Price (US$/ton) by Region (2021-2026) Table 54. Global 8-Methoxypsoralen Market Average Price (US$/ton) by Region (2027-2032) Table 55. Global 8-Methoxypsoralen Sales by Country: 2021 VS 2025 VS 2032 (k tons) Table 56. Global 8-Methoxypsoralen Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global 8-Methoxypsoralen Sales by Country (2021-2026) & (k tons) Table 58. Global 8-Methoxypsoralen Sales Market Share by Country (2021-2026) Table 59. Global 8-Methoxypsoralen Sales by Country (2027-2032) & (k tons) Table 60. Global 8-Methoxypsoralen Sales Market Share by Country (2027-2032) Table 61. Global 8-Methoxypsoralen Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global 8-Methoxypsoralen Sales Value Market Share by Country (2021-2026) Table 63. Global 8-Methoxypsoralen Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global 8-Methoxypsoralen Sales Value Market Share by Country (2027-2032) Table 65. Wuxi Sigma Chemical Product Company Information Table 66. Wuxi Sigma Chemical Product Business Overview Table 67. Wuxi Sigma Chemical Product 8-Methoxypsoralen Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 68. Wuxi Sigma Chemical Product 8-Methoxypsoralen Product Portfolio Table 69. Wuxi Sigma Chemical Product Recent Development Table 70. Fisher Scientific Company Information Table 71. Fisher Scientific Business Overview Table 72. Fisher Scientific 8-Methoxypsoralen Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 73. Fisher Scientific 8-Methoxypsoralen Product Portfolio Table 74. Fisher Scientific Recent Development Table 75. Combi-Blocks Company Information Table 76. Combi-Blocks Business Overview Table 77. Combi-Blocks 8-Methoxypsoralen Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 78. Combi-Blocks 8-Methoxypsoralen Product Portfolio Table 79. Combi-Blocks Recent Development Table 80. TCI Chemicals Company Information Table 81. TCI Chemicals Business Overview Table 82. TCI Chemicals 8-Methoxypsoralen Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 83. TCI Chemicals 8-Methoxypsoralen Product Portfolio Table 84. TCI Chemicals Recent Development Table 85. Spectrum-Chemical Products Company Information Table 86. Spectrum-Chemical Products Business Overview Table 87. Spectrum-Chemical Products 8-Methoxypsoralen Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 88. Spectrum-Chemical Products 8-Methoxypsoralen Product Portfolio Table 89. Spectrum-Chemical Products Recent Development Table 90. MP Biomedicals Company Information Table 91. MP Biomedicals Business Overview Table 92. MP Biomedicals 8-Methoxypsoralen Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 93. MP Biomedicals 8-Methoxypsoralen Product Portfolio Table 94. MP Biomedicals Recent Development Table 95. MedKoo Biosciences Company Information Table 96. MedKoo Biosciences Business Overview Table 97. MedKoo Biosciences 8-Methoxypsoralen Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 98. MedKoo Biosciences 8-Methoxypsoralen Product Portfolio Table 99. MedKoo Biosciences Recent Development Table 100. Medical Isotopes Company Information Table 101. Medical Isotopes Business Overview Table 102. Medical Isotopes 8-Methoxypsoralen Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 103. Medical Isotopes 8-Methoxypsoralen Product Portfolio Table 104. Medical Isotopes Recent Development Table 105. LGM Pharma Company Information Table 106. LGM Pharma Business Overview Table 107. LGM Pharma 8-Methoxypsoralen Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 108. LGM Pharma 8-Methoxypsoralen Product Portfolio Table 109. LGM Pharma Recent Development Table 110. BOC Sciences Company Information Table 111. BOC Sciences Business Overview Table 112. BOC Sciences 8-Methoxypsoralen Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 113. BOC Sciences 8-Methoxypsoralen Product Portfolio Table 114. BOC Sciences Recent Development Table 115. ApexBio Company Information Table 116. ApexBio Business Overview Table 117. ApexBio 8-Methoxypsoralen Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 118. ApexBio 8-Methoxypsoralen Product Portfolio Table 119. ApexBio Recent Development Table 120. Alfa Aesar Company Information Table 121. Alfa Aesar Business Overview Table 122. Alfa Aesar 8-Methoxypsoralen Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 123. Alfa Aesar 8-Methoxypsoralen Product Portfolio Table 124. Alfa Aesar Recent Development Table 125. ALB Technology Company Information Table 126. ALB Technology Business Overview Table 127. ALB Technology 8-Methoxypsoralen Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 128. ALB Technology 8-Methoxypsoralen Product Portfolio Table 129. ALB Technology Recent Development Table 130. AdipoGen Company Information Table 131. AdipoGen Business Overview Table 132. AdipoGen 8-Methoxypsoralen Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 133. AdipoGen 8-Methoxypsoralen Product Portfolio Table 134. AdipoGen Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. 8-Methoxypsoralen Distributors List Table 138. 8-Methoxypsoralen Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. 8-Methoxypsoralen Product Image Figure 2. Global 8-Methoxypsoralen Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 8-Methoxypsoralen Sales Value (2021-2032) & (US$ Million) Figure 4. Global 8-Methoxypsoralen Sales (2021-2032) & (k tons) Figure 5. Global 8-Methoxypsoralen Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global 8-Methoxypsoralen Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Type Image Figure 10. External Use Image Figure 11. Global 8-Methoxypsoralen Sales Volume by Type (2021 VS 2025 VS 2032) & (k tons) Figure 12. Global 8-Methoxypsoralen Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global 8-Methoxypsoralen Sales Volume Share by Type (2021-2032) Figure 14. Global 8-Methoxypsoralen Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global 8-Methoxypsoralen Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global 8-Methoxypsoralen Sales Value Share by Type (2021-2032) Figure 17. Antiarrhythmic Drugs Image Figure 18. Anti-inflammatory Drugs Image Figure 19. Analgesic Drugs Image Figure 20. Others Image Figure 21. Global 8-Methoxypsoralen Sales Volume by Application (2021 VS 2025 VS 2032) & (k tons) Figure 22. Global 8-Methoxypsoralen Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global 8-Methoxypsoralen Sales Volume Share by Application (2021-2032) Figure 24. Global 8-Methoxypsoralen Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global 8-Methoxypsoralen Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global 8-Methoxypsoralen Sales Value Share by Application (2021-2032) Figure 27. Global 8-Methoxypsoralen Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 28. Global 8-Methoxypsoralen Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global 8-Methoxypsoralen Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global 8-Methoxypsoralen Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America 8-Methoxypsoralen Sales Value (2021-2032) & (US$ Million) Figure 32. North America 8-Methoxypsoralen Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe 8-Methoxypsoralen Sales Value (2021-2032) & (US$ Million) Figure 34. Europe 8-Methoxypsoralen Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific 8-Methoxypsoralen Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific 8-Methoxypsoralen Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America 8-Methoxypsoralen Sales Value (2021-2032) & (US$ Million) Figure 38. South America 8-Methoxypsoralen Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa 8-Methoxypsoralen Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa 8-Methoxypsoralen Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt 8-Methoxypsoralen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. 8-Methoxypsoralen Value Chain Figure 126. Manufacturing Cost Structure Figure 127. 8-Methoxypsoralen Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Type
  • External Use
Applications
  • Antiarrhythmic Drugs
  • Anti-inflammatory Drugs
  • Analgesic Drugs
  • Others
Companies covered
  • Wuxi Sigma Chemical Product
  • Fisher Scientific
  • Combi-Blocks
  • TCI Chemicals
  • Spectrum-Chemical Products
  • MP Biomedicals
  • MedKoo Biosciences
  • Medical Isotopes
  • LGM Pharma
  • BOC Sciences
  • ApexBio
  • Alfa Aesar
  • ALB Technology
  • AdipoGen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 8-Methoxypsoralen Sales Value (2021-2032)
  4. 1.2.2 Global 8-Methoxypsoralen Sales Volume (2021-2032)
  5. 1.2.3 Global 8-Methoxypsoralen Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 8-Methoxypsoralen Market Dynamics
  1. 2.1 8-Methoxypsoralen Industry Trends
  2. 2.2 8-Methoxypsoralen Industry Drivers
  3. 2.3 8-Methoxypsoralen Industry Opportunities and Challenges
  4. 2.4 8-Methoxypsoralen Industry Restraints
3 8-Methoxypsoralen Market by Company
  1. 3.1 Global 8-Methoxypsoralen Company Revenue Ranking in 2025
  2. 3.2 Global 8-Methoxypsoralen Revenue by Company (2021-2026)
  3. 3.3 Global 8-Methoxypsoralen Sales Volume by Company (2021-2026)
  4. 3.4 Global 8-Methoxypsoralen Average Price by Company (2021-2026)
  5. 3.5 Global 8-Methoxypsoralen Company Ranking (2024-2026)
  6. 3.6 Global 8-Methoxypsoralen Company Manufacturing Base and Headquarters
  7. 3.7 Global 8-Methoxypsoralen Company Product Type and Application
  8. 3.8 Global 8-Methoxypsoralen Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global 8-Methoxypsoralen Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 8-Methoxypsoralen Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 8-Methoxypsoralen Market by Type
  1. 4.1 8-Methoxypsoralen Type Introduction
  2. 4.1.1 Oral Type
  3. 4.1.2 External Use
  4. 4.2 Global 8-Methoxypsoralen Sales Volume by Type
  5. 4.2.1 Global 8-Methoxypsoralen Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global 8-Methoxypsoralen Sales Volume by Type (2021-2032)
  7. 4.2.3 Global 8-Methoxypsoralen Sales Volume Share by Type (2021-2032)
  8. 4.3 Global 8-Methoxypsoralen Sales Value by Type
  9. 4.3.1 Global 8-Methoxypsoralen Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global 8-Methoxypsoralen Sales Value by Type (2021-2032)
  11. 4.3.3 Global 8-Methoxypsoralen Sales Value Share by Type (2021-2032)
5 8-Methoxypsoralen Market by Application
  1. 5.1 8-Methoxypsoralen Application Introduction
  2. 5.1.1 Antiarrhythmic Drugs
  3. 5.1.2 Anti-inflammatory Drugs
  4. 5.1.3 Analgesic Drugs
  5. 5.1.4 Others
  6. 5.2 Global 8-Methoxypsoralen Sales Volume by Application
  7. 5.2.1 Global 8-Methoxypsoralen Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global 8-Methoxypsoralen Sales Volume by Application (2021-2032)
  9. 5.2.3 Global 8-Methoxypsoralen Sales Volume Share by Application (2021-2032)
  10. 5.3 Global 8-Methoxypsoralen Sales Value by Application
  11. 5.3.1 Global 8-Methoxypsoralen Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global 8-Methoxypsoralen Sales Value by Application (2021-2032)
  13. 5.3.3 Global 8-Methoxypsoralen Sales Value Share by Application (2021-2032)
6 8-Methoxypsoralen Regional Sales and Value Analysis
  1. 6.1 Global 8-Methoxypsoralen Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global 8-Methoxypsoralen Sales by Region (2021-2032)
  3. 6.2.1 Global 8-Methoxypsoralen Sales by Region: 2021-2026
  4. 6.2.2 Global 8-Methoxypsoralen Sales by Region (2027-2032)
  5. 6.3 Global 8-Methoxypsoralen Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global 8-Methoxypsoralen Sales Value by Region (2021-2032)
  7. 6.4.1 Global 8-Methoxypsoralen Sales Value by Region: 2021-2026
  8. 6.4.2 Global 8-Methoxypsoralen Sales Value by Region (2027-2032)
  9. 6.5 Global 8-Methoxypsoralen Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America 8-Methoxypsoralen Sales Value (2021-2032)
  12. 6.6.2 North America 8-Methoxypsoralen Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe 8-Methoxypsoralen Sales Value (2021-2032)
  15. 6.7.2 Europe 8-Methoxypsoralen Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific 8-Methoxypsoralen Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific 8-Methoxypsoralen Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America 8-Methoxypsoralen Sales Value (2021-2032)
  21. 6.9.2 South America 8-Methoxypsoralen Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa 8-Methoxypsoralen Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa 8-Methoxypsoralen Sales Value Share by Country, 2025 VS 2032
7 8-Methoxypsoralen Country-level Sales and Value Analysis
  1. 7.1 Global 8-Methoxypsoralen Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global 8-Methoxypsoralen Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global 8-Methoxypsoralen Sales by Country (2021-2032)
  4. 7.3.1 Global 8-Methoxypsoralen Sales by Country (2021-2026)
  5. 7.3.2 Global 8-Methoxypsoralen Sales by Country (2027-2032)
  6. 7.4 Global 8-Methoxypsoralen Sales Value by Country (2021-2032)
  7. 7.4.1 Global 8-Methoxypsoralen Sales Value by Country (2021-2026)
  8. 7.4.2 Global 8-Methoxypsoralen Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt 8-Methoxypsoralen Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt 8-Methoxypsoralen Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt 8-Methoxypsoralen Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wuxi Sigma Chemical Product
  2. 8.1.1 Wuxi Sigma Chemical Product Company Information
  3. 8.1.2 Wuxi Sigma Chemical Product Business Overview
  4. 8.1.3 Wuxi Sigma Chemical Product 8-Methoxypsoralen Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Wuxi Sigma Chemical Product 8-Methoxypsoralen Product Portfolio
  6. 8.1.5 Wuxi Sigma Chemical Product Recent Developments
  7. 8.2 Fisher Scientific
  8. 8.2.1 Fisher Scientific Company Information
  9. 8.2.2 Fisher Scientific Business Overview
  10. 8.2.3 Fisher Scientific 8-Methoxypsoralen Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Fisher Scientific 8-Methoxypsoralen Product Portfolio
  12. 8.2.5 Fisher Scientific Recent Developments
  13. 8.3 Combi-Blocks
  14. 8.3.1 Combi-Blocks Company Information
  15. 8.3.2 Combi-Blocks Business Overview
  16. 8.3.3 Combi-Blocks 8-Methoxypsoralen Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Combi-Blocks 8-Methoxypsoralen Product Portfolio
  18. 8.3.5 Combi-Blocks Recent Developments
  19. 8.4 TCI Chemicals
  20. 8.4.1 TCI Chemicals Company Information
  21. 8.4.2 TCI Chemicals Business Overview
  22. 8.4.3 TCI Chemicals 8-Methoxypsoralen Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 TCI Chemicals 8-Methoxypsoralen Product Portfolio
  24. 8.4.5 TCI Chemicals Recent Developments
  25. 8.5 Spectrum-Chemical Products
  26. 8.5.1 Spectrum-Chemical Products Company Information
  27. 8.5.2 Spectrum-Chemical Products Business Overview
  28. 8.5.3 Spectrum-Chemical Products 8-Methoxypsoralen Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Spectrum-Chemical Products 8-Methoxypsoralen Product Portfolio
  30. 8.5.5 Spectrum-Chemical Products Recent Developments
  31. 8.6 MP Biomedicals
  32. 8.6.1 MP Biomedicals Company Information
  33. 8.6.2 MP Biomedicals Business Overview
  34. 8.6.3 MP Biomedicals 8-Methoxypsoralen Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 MP Biomedicals 8-Methoxypsoralen Product Portfolio
  36. 8.6.5 MP Biomedicals Recent Developments
  37. 8.7 MedKoo Biosciences
  38. 8.7.1 MedKoo Biosciences Company Information
  39. 8.7.2 MedKoo Biosciences Business Overview
  40. 8.7.3 MedKoo Biosciences 8-Methoxypsoralen Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 MedKoo Biosciences 8-Methoxypsoralen Product Portfolio
  42. 8.7.5 MedKoo Biosciences Recent Developments
  43. 8.8 Medical Isotopes
  44. 8.8.1 Medical Isotopes Company Information
  45. 8.8.2 Medical Isotopes Business Overview
  46. 8.8.3 Medical Isotopes 8-Methoxypsoralen Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Medical Isotopes 8-Methoxypsoralen Product Portfolio
  48. 8.8.5 Medical Isotopes Recent Developments
  49. 8.9 LGM Pharma
  50. 8.9.1 LGM Pharma Company Information
  51. 8.9.2 LGM Pharma Business Overview
  52. 8.9.3 LGM Pharma 8-Methoxypsoralen Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 LGM Pharma 8-Methoxypsoralen Product Portfolio
  54. 8.9.5 LGM Pharma Recent Developments
  55. 8.10 BOC Sciences
  56. 8.10.1 BOC Sciences Company Information
  57. 8.10.2 BOC Sciences Business Overview
  58. 8.10.3 BOC Sciences 8-Methoxypsoralen Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 BOC Sciences 8-Methoxypsoralen Product Portfolio
  60. 8.10.5 BOC Sciences Recent Developments
  61. 8.11 ApexBio
  62. 8.11.1 ApexBio Company Information
  63. 8.11.2 ApexBio Business Overview
  64. 8.11.3 ApexBio 8-Methoxypsoralen Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 ApexBio 8-Methoxypsoralen Product Portfolio
  66. 8.11.5 ApexBio Recent Developments
  67. 8.12 Alfa Aesar
  68. 8.12.1 Alfa Aesar Company Information
  69. 8.12.2 Alfa Aesar Business Overview
  70. 8.12.3 Alfa Aesar 8-Methoxypsoralen Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Alfa Aesar 8-Methoxypsoralen Product Portfolio
  72. 8.12.5 Alfa Aesar Recent Developments
  73. 8.13 ALB Technology
  74. 8.13.1 ALB Technology Company Information
  75. 8.13.2 ALB Technology Business Overview
  76. 8.13.3 ALB Technology 8-Methoxypsoralen Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 ALB Technology 8-Methoxypsoralen Product Portfolio
  78. 8.13.5 ALB Technology Recent Developments
  79. 8.14 AdipoGen
  80. 8.14.1 AdipoGen Company Information
  81. 8.14.2 AdipoGen Business Overview
  82. 8.14.3 AdipoGen 8-Methoxypsoralen Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 AdipoGen 8-Methoxypsoralen Product Portfolio
  84. 8.14.5 AdipoGen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 8-Methoxypsoralen Value Chain Analysis
  2. 9.1.1 8-Methoxypsoralen Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 8-Methoxypsoralen Sales Mode & Process
  6. 9.2 8-Methoxypsoralen Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 8-Methoxypsoralen Distributors
  9. 9.2.3 8-Methoxypsoralen Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst